american diabetes association history of pancreatitis glp-1 receptor agonist Risk all–cause death and pancreatic events following RA initiation in people with obesity or type 2 diabetes: observations from a federated research network | Cardiovascular Diabetology GLP-1 Agonists in Cardiovascular Diseases:

Increasing cellular nad+ Protects hepatocytes against palmitate-induced lipotoxicity by preventing parp-1 inhibition and the mtorc1-P300 pathway activation

[DOI] [PubMed] [Google Scholar] Sadhu S.S., Xie J., Zhang H., Perumal O., Guan X

The hormone GLP-1 is also a neurotransmitter and communicates directly with an area in the brain that regulates appetite, called the hypothalamus

This phenomenon could be explained by the increased levels of TGF-1, a cytokine known to decrease the expression of GCLC ( M

It highlights its immunomodulatory, antioxidant, antimicrobial, antifungal, anticancer (skin, oral, lung, breast, cervical), antidepressant, anxiolytic, cardiovascular, chemopreventive, and anti-angiogenic properties

A.Ambale-VenkateshB.JorgensenN